Boothbay Fund Management, LLC Gritstone Bio, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.03 $88,121 - $160,847	53,085 Added 21.33%	301,939 $588,000
Q1 2023 May 15, 2023	BUY	$2.13 - $3.74 $470,184 - $825,582	220,744 Added 785.29%	248,854 $691,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $3.92 $60,998 - $110,191	28,110 New	28,110 $96,000
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $24,951 - $61,180	14,097 New	14,097 $34,000
Q2 2019 Aug 14, 2019	SELL	$9.2 - $15.7 $147,200 - $251,200	-16,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$9.97 - $18.96 $159,520 - $303,360	16,000 New	16,000 $213,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.